SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Pharmaceuticals & Chemicals informs about company updates

17 May 2017 Evaluate

Dishman Pharmaceuticals & Chemicals has informed that the meeting of the Management Committee of Board of Directors of amalgamated entity i.e. Dishman Carbogen Amcis Limited (DCAL) [formerly known as Carbogen Amcis (India)] will be held on Friday, the 19th day of May, 2017 at 11:00 a.m. at Ahmedabad, to fix the Record Date for the purpose of deciding the members who shall be eligible for allotment of equity shares of Dishman Carbogen Amcis to the shareholders of Dishman Pharmaceuticals and Chemicals in the ratio of 1:1 i.e. Share Exchange Ratio, fixed under the Scheme of Merger approved by the Hon’ble High Court of Gujarat.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1233.20
Cipla 1232.00
Zydus Lifesciences 937.70
Lupin 2327.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×